Income Taxes
The components of loss before income taxes were as follows (in thousands):
| | | | | | | | | | | | | | | | | |
| Year Ended December 31, |
| 2025 | | 2024 | | 2023 |
| United States | $ | 36,399 | | | $ | 126,341 | | | $ | 62,745 | |
| International | 11,829 | | | (1,643) | | | (2,236) | |
| $ | 48,228 | | | $ | 124,698 | | | $ | 60,509 | |
The components of the total provision for (benefit from) income taxes were as follows (in thousands):
| | | | | | | | | | | | | | | | | |
| Year Ended December 31, |
| 2025 | | 2024 | | 2023 |
| Current | | | | | |
| Federal | $ | 738 | | | $ | 4,474 | | | $ | 272 | |
| State | 1,887 | | | 3,872 | | | 859 | |
| Foreign | 3,298 | | | 3,361 | | | 1,844 | |
| Total current tax expense | 5,923 | | | 11,707 | | | 2,975 | |
| Deferred | | | | | |
| Federal | 15,076 | | | (35,071) | | | 202 | |
| State | 886 | | | (17,791) | | | 100 | |
| Foreign | (914) | | | (1,912) | | | (1,827) | |
| Total deferred tax provision | 15,048 | | | (54,774) | | | (1,525) | |
| Total provision for (benefit from) income taxes | $ | 20,971 | | | $ | (43,067) | | | $ | 1,450 | |
A reconciliation of the statutory U.S. federal income tax rate to the Company’s effective tax rate pursuant to the disclosure requirements of ASU 2023-09 adopted on a prospective basis for the year ended December 31, 2025 was as follows (in thousands, except percentages):
| | | | | | | | | | | |
| Year Ended December 31, |
| 2025 |
| Federal statutory income tax rate | $ | 10,128 | | | 21.0 | % |
State tax, net of federal benefit(1) | 2,379 | | | 4.9 | % |
| Change in valuation allowance | (86) | | | (0.2) | % |
| Foreign tax effects: | | | |
| Japan | | | |
| Change in valuation allowance | (2,344) | | | (4.9) | % |
| Other | 658 | | | 1.4 | % |
| Netherlands | | | |
| Statutory tax rate difference | 463 | | | 1.0 | % |
| Other | 109 | | | 0.2 | % |
| Other foreign jurisdictions | 990 | | | 2.1 | % |
| Cross-border tax laws: | | | |
| Base erosion and anti-abuse tax | 1,280 | | | 2.7 | % |
| Subpart F income | 1,115 | | | 2.3 | % |
| Tax credits | (3,857) | | | (8.0) | % |
| Nondeductible items: | | | |
| Officer compensation | 5,188 | | | 10.8 | % |
| Meals & entertainment | 625 | | | 1.3 | % |
| Stock-based compensation | 4,547 | | | 9.4 | % |
| Other | (224) | | | (0.5) | % |
| Total | $ | 20,971 | | | 43.5 | % |
(1) State and local taxes in California, Minnesota, New York City, Pennsylvania, and Texas made up the majority (greater than 50 percent) of the state tax effect.
A reconciliation of the statutory U.S. federal income tax rate to the Company’s effective tax rate for the years ended December 31, 2024 and 2023 prior to the adoption of ASU 2023-09 was as follows:
| | | | | | | | | | | | | |
| | | Year Ended December 31, |
| | | 2024 | | 2023 |
| Federal statutory income tax rate | | | 21.0 | % | | 21.0 | % |
| State tax, net of federal benefit | | | (11.8) | % | | 2.7 | % |
| Federal tax credits | | | (2.5) | % | | (9.8) | % |
| De-recognized tax credit carryforwards | | | 2.6 | % | | — | % |
| Unrecognized tax benefit remeasurement | | | 4.3 | % | | — | % |
| Change in valuation allowance | | | (53.2) | % | | (13.8) | % |
| Foreign tax differential | | | 0.9 | % | | 2.0 | % |
| Windfall tax benefits, net related to stock-based compensation | | | 1.8 | % | | 4.1 | % |
| | | | | |
| Nondeductible officer compensation | | | 3.9 | % | | 6.8 | % |
| Nondeductible transaction costs | | | — | % | | 0.3 | % |
| Contingent consideration | | | — | % | | (11.6) | % |
| Nondeductible meals and entertainment | | | 0.5 | % | | 0.7 | % |
| Foreign-derived intangible income tax benefit | | | (1.8) | % | | — | % |
| Other | | | (0.2) | % | | — | % |
| | | (34.5) | % | | 2.4 | % |
On July 4, 2025, the legislation formally titled “An Act to Provide for Reconciliation Pursuant to Title II of H. Con. Res. 14” and commonly referred to as the “One Big Beautiful Bill” (“OBBB”) was enacted. The OBBB adjusted a number of provisions affecting businesses, including the immediate expensing of domestic research and development costs, limitations on deductions for interest expense, and accelerated fixed asset depreciation. The OBBB provisions did not have a material impact on the Company’s effective tax rate.
The summary of income taxes paid by jurisdiction pursuant to the disclosure requirements of ASU 2023-09 adopted on a prospective basis for the year ended December 31, 2025 (in thousands):
| | | | | |
| Year Ended December 31, |
| 2025 |
| Federal | $ | 650 | |
| State | 2,676 | |
| Foreign | |
| France | 424 | |
| India | 873 | |
| Mexico | 409 | |
| Netherlands | 1,751 | |
| United Kingdom | (810) | |
| All other foreign | 550 | |
| Total | $ | 6,523 | |
The amount of cash income taxes paid by the Company during the years ended December 31, 2024 and 2023 was $11.5 million and $3.1 million, respectively.
Significant components of the Company’s deferred tax assets and liabilities were as follows (in thousands):
| | | | | | | | | | | |
| December 31, |
| 2025 | | 2024 |
| Deferred tax assets | | | |
| Net operating loss carryforwards | $ | 34,022 | | | $ | 14,906 | |
| Research and other credits | 21,991 | | | 17,288 | |
| Capitalized R&D | 3,049 | | | 40,131 | |
| Stock-based compensation | 8,028 | | | 7,570 | |
| Operating and finance leases | 2,496 | | | 3,382 | |
| | | |
| Accrued expenses and other current liabilities | 5,948 | | | 7,300 | |
| Other | 1,114 | | | 2,962 | |
| Total deferred tax assets | 76,648 | | | 93,539 | |
| Less: valuation allowance | (2,247) | | | (4,677) | |
| Deferred tax assets, net of valuation allowance | 74,401 | | | 88,862 | |
| Deferred tax liabilities | | | |
| | | |
| Intangible assets | (11,499) | | | (13,801) | |
| Prepaid expenses | (26,236) | | | (23,194) | |
| | | |
| Operating lease right-of-use and finance lease assets | (2,453) | | | (3,191) | |
| | | |
| Other | (116) | | | — | |
| Total deferred tax liabilities | (40,304) | | | (40,186) | |
| Net deferred taxes | $ | 34,097 | | | $ | 48,676 | |
ASC 740, Income Taxes, requires that the tax benefit of net operating losses, temporary differences, and credit carryforwards be recorded as an asset to the extent that management assesses that realization is “more likely than not.” A valuation allowance is recorded when it is more likely than not that some of the deferred tax assets will not be realized. Realization of future tax benefits is dependent on the Company’s ability to generate sufficient taxable income within the carryforward period. Accordingly, the Company provided a valuation allowance against certain foreign deferred tax assets.
The changes in the valuation allowance were as follows (in thousands):
| | | | | | | | | | | | | | | | | |
| Year Ended December 31, |
| 2025 | | 2024 | | 2023 |
| Valuation allowance, at beginning of year | $ | 4,677 | | | $ | 92,079 | | | $ | 99,476 | |
| Decrease in valuation allowance recorded through earnings | (2,430) | | | (87,402) | | | (7,063) | |
| Decrease in valuation allowance recorded through equity | — | | | — | | | (334) | |
| Valuation allowance, at end of year | $ | 2,247 | | | $ | 4,677 | | | $ | 92,079 | |
The decrease in valuation allowance recorded through earnings of $2.4 million during the year ended December 31, 2025 resulted primarily from the release of valuation allowance previously recorded against its BlackLine K.K. deferred tax assets.
The decrease in valuation allowance recorded through earnings of $87.4 million during the year ended December 31, 2024 resulted primarily from the release of valuation allowance previously recorded against its U.S. deferred tax assets, partially offset by an increase in valuation allowance recorded against certain foreign deferred tax assets.
The decrease in valuation allowance recorded through earnings of $7.1 million for the year ended December 31, 2023 resulted primarily from the utilization of federal and state net operating loss carryforwards due to domestic profitability, along with the valuation allowance decrease associated with net deferred tax liabilities from the DI Acquisition, which are a source of taxable income to support the recognition of existing UK deferred tax assets. The valuation allowance release resulted in a UK deferred tax benefit of $1.7 million for the year ended December 31, 2023.
The decrease in valuation allowance recorded through equity of $0.3 million during the year ended December 31, 2023 is related to unrealized gains reported in other comprehensive income.
The Company did not provide for U.S. income taxes on the undistributed earnings and other outside temporary differences of foreign subsidiaries at December 31, 2025 and 2024, as they are considered indefinitely reinvested outside the U.S. and determination is not practicable. Upon distribution of those earnings in the form of a
dividend or otherwise, the Company may be subject to both state income taxes and withholding taxes payable to various foreign countries. The amounts of such tax liabilities that might be payable upon repatriation of foreign earnings are not material.
At December 31, 2025, the Company had consolidated federal and state net operating loss carryforwards available to offset future taxable income of approximately $81.4 million and $82.9 million, respectively. The federal losses do not expire, and the state losses will begin to expire between 2031 and 2045, depending on the jurisdiction. The Company has federal research and development credits of $9.8 million, which begin to expire in 2041. The Company has state research and development credits of $12.1 million, which are indefinite in expiration. Pursuant to Internal Revenue Code Section 382, use of the Company’s net operating loss carryforwards may be limited if the Company experiences a cumulative change in ownership of more than 50% over a three-year period.
The following is a rollforward of the Company’s total gross unrecognized tax benefits (in thousands):
| | | | | | | | | | | | | | | | | |
| Year Ended December 31, |
| 2025 | | 2024 | | 2023 |
| Beginning gross unrecognized tax benefits | $ | 18,698 | | | $ | 7,104 | | | $ | 5,513 | |
| Increases related to prior year tax positions | 695 | | | 9,243 | | | 274 | |
| Increases related to current year tax positions | 2,665 | | | 2,351 | | | 1,317 | |
| Settlements | (84) | | | — | | | — | |
| Ending gross unrecognized tax benefits | $ | 21,974 | | | $ | 18,698 | | | $ | 7,104 | |
At December 31, 2025, included in the balance of unrecognized tax benefits is $22.0 million, that if recognized, would affect the effective tax rate. The Company recorded less than $0.1 million interest and penalties in its provision for income taxes for the years ended December 31, 2025, 2024, and 2023, respectively. No interest and penalties were accrued for at December 31, 2025, and less than $0.1 million was accrued in interest and penalties at December 31, 2024.
The Company files U.S. federal, various state, and foreign income tax returns. In the normal course of business, the Company is subject to examination by taxing authorities. The tax years from 2013 forward remain subject to examination for federal purposes. Generally, state and foreign tax authorities may examine the Company’s tax returns for four years and five years, respectively, from the date an income tax return is filed. However, the taxing authorities may continue to examine the Company’s federal and state net operating loss carryforward until the statute of limitations closes on the tax years in which the federal and state net operating losses are utilized.
The Company does not anticipate material changes in the total amount or composition of its unrecognized tax benefits within 12 months of the reporting date.